{
  "outline": [
    [
      1,
      "A Survey of PRISMA-DTA in Diagnostic Test Accuracy Studies"
    ],
    [
      1,
      "1 Abstract"
    ],
    [
      1,
      "2 Introduction"
    ],
    [
      1,
      "3 Statistical Methods for Diagnostic Accuracy Analysis"
    ],
    [
      2,
      "3.1 Methodological Foundations of Diagnostic Accuracy"
    ],
    [
      3,
      "3.1.1 Bayesian and Frequentist Approaches to Sample Size Determination"
    ],
    [
      3,
      "3.1.2 Sensitivity Analysis for Publication Bias and Data Quality"
    ],
    [
      2,
      "3.2 Advanced Statistical Modeling for Diagnostic Evaluation"
    ],
    [
      3,
      "3.2.1 Nonparametric and Likelihood-Based Techniques for ROC Curve Analysis"
    ],
    [
      3,
      "3.2.2 Transformation Models for Covariate-Adjusted Diagnostic Performance"
    ],
    [
      2,
      "3.3 Computational and Simulation-Based Diagnostic Assessment"
    ],
    [
      3,
      "3.3.1 Empirical Evaluation of Diagnostic Reliability Under Variability"
    ],
    [
      3,
      "3.3.2 Simulation-Driven Analysis of Diagnostic Accuracy and Uncertainty"
    ],
    [
      1,
      "4 Machine Learning and AI in Medical Diagnostics"
    ],
    [
      2,
      "4.1 Machine Learning for Diagnostic Classification and Prediction"
    ],
    [
      3,
      "4.1.1 Deep Learning Architectures for Medical Imaging and Biomarker Analysis"
    ],
    [
      3,
      "4.1.2 Ensemble and Transfer Learning Strategies for Diagnostic Enhancement"
    ],
    [
      2,
      "4.2 AI-Driven Diagnostic Tools and Their Validation"
    ],
    [
      3,
      "4.2.1 Application of Neural Networks in Rapid Test Image Analysis"
    ],
    [
      3,
      "4.2.2 Integration of AI with Traditional Diagnostic Techniques"
    ],
    [
      2,
      "4.3 Computational Methods for Biomedical Data Interpretation"
    ],
    [
      3,
      "4.3.1 Temporal Modeling of Lab Test Records for Predictive Diagnostics"
    ],
    [
      3,
      "4.3.2 Feature Selection and Model Optimization in AI-Based Diagnostics"
    ],
    [
      1,
      "5 Systematic Reviews and Benchmarking of Diagnostic Tools"
    ],
    [
      2,
      "5.1 Systematic Evaluation of Diagnostic Technologies"
    ],
    [
      3,
      "5.1.1 Comparative Analysis of AI and Conventional Diagnostic Systems"
    ],
    [
      3,
      "5.1.2 Meta-Analysis of Diagnostic Accuracy Across Medical Domains"
    ],
    [
      2,
      "5.2 Benchmarking of Machine Learning Models in Diagnostic Tasks"
    ],
    [
      3,
      "5.2.1 Performance Assessment of LLMs in Clinical Question Answering"
    ],
    [
      3,
      "5.2.2 Case Studies on AI Model Behavior in Complex Medical Scenarios"
    ],
    [
      2,
      "5.3 Methodological Rigor in Diagnostic Tool Reviews"
    ],
    [
      3,
      "5.3.1 Systematic Review Frameworks for Diagnostic Accuracy Studies"
    ],
    [
      3,
      "5.3.2 Meta-Analysis Techniques for Diagnostic Test Evaluation"
    ],
    [
      1,
      "6 Future Directions"
    ],
    [
      1,
      "7 Conclusion"
    ],
    [
      1,
      "References"
    ]
  ],
  "content": [
    {
      "heading": "A Survey of PRISMA-DTA in Diagnostic Test Accuracy Studies",
      "level": 1,
      "content": ""
    },
    {
      "heading": "1 Abstract",
      "level": 1,
      "content": "Diagnostic test accuracy (DTA) studies play a critical role in evaluating the reliability and precision of medical diagnostics, with significant implications for clinical decision-making and patient outcomes. Over the past few decades, advancements in statistical methodologies and computational techniques have enhanced the ability to assess diagnostic performance, particularly in complex areas such as oncology and neurology. This survey paper provides a comprehensive analysis of the methodological and computational approaches used in DTA studies, with a focus on statistical modeling, machine learning, and the integration of artificial intelligence. The paper examines key topics including Bayesian and frequentist sample size determination, sensitivity analysis for publication bias, nonparametric and likelihood-based ROC curve analysis, and transformation models for covariate-adjusted diagnostic performance. It also explores the growing role of machine learning in medical diagnostics, emphasizing deep learning architectures, ensemble learning, and the application of AI in rapid test image analysis. The survey highlights the strengths and limitations of current methodologies, identifies gaps in research, and suggests areas for future development. By synthesizing existing literature and evaluating the evolving landscape of diagnostic evaluation, this paper contributes to the ongoing efforts to improve the quality, reliability, and clinical applicability of diagnostic test accuracy studies. The integration of advanced statistical and computational techniques is essential for addressing the complexities of real-world data and ensuring the validity of diagnostic accuracy estimates in diverse clinical settings."
    },
    {
      "heading": "2 Introduction",
      "level": 1,
      "content": "The field of diagnostic test accuracy (DTA) has seen significant advancements over the past few decades, driven by the increasing demand for reliable and precise medical diagnostics. As healthcare systems strive to improve patient outcomes, the need for robust methods to evaluate the performance of diagnostic tests has become more critical. DTA studies aim to quantify the ability of a test to correctly identify individuals with or without a particular condition, providing essential evidence for clinical decision-making. These studies are particularly important in areas such as oncology, neurology, and infectious diseases, where early and accurate diagnosis can significantly influence treatment strategies and patient prognosis. The development of statistical methodologies for DTA has evolved in response to the complexities of real-world data, including variations in study design, population heterogeneity, and the presence of biases such as publication bias and partial verification bias. These challenges necessitate the use of advanced analytical techniques to ensure the validity and generalizability of diagnostic accuracy estimates [1].\n\nThe research topic of this survey paper is the comprehensive evaluation of statistical methods and computational techniques used in diagnostic test accuracy studies, with a particular focus on the PRISMA-DTA guidelines. This paper aims to provide an in-depth analysis of the methodological foundations, advanced statistical modeling, and computational approaches that underpin the evaluation of diagnostic accuracy [1]. By synthesizing existing literature and examining the current state of the field, this survey offers insights into the strengths and limitations of various methodologies, as well as their applicability in different clinical contexts. The paper also explores the integration of machine learning and artificial intelligence in diagnostic evaluation, highlighting the potential of these technologies to enhance the accuracy and efficiency of diagnostic processes [2]. Through this analysis, the survey contributes to the ongoing discourse on improving the quality and reliability of diagnostic test accuracy studies.\n\nThe survey paper covers a wide range of topics, beginning with the methodological foundations of diagnostic accuracy, including Bayesian and frequentist approaches to sample size determination and sensitivity analysis for publication bias and data quality [3]. These sections provide a critical overview of the statistical principles that underpin DTA studies, emphasizing the importance of appropriate study design and the impact of biases on diagnostic accuracy. The paper then delves into advanced statistical modeling techniques, such as nonparametric and likelihood-based methods for ROC curve analysis, as well as transformation models for covariate-adjusted diagnostic performance [4]. These models are essential for handling complex data structures and incorporating patient-specific factors into diagnostic evaluations. The discussion also extends to computational and simulation-based diagnostic assessment, where empirical evaluations and simulation-driven analyses are used to assess the reliability of diagnostic tests under various conditions. These sections highlight the evolving landscape of diagnostic evaluation and the increasing reliance on computational tools to address methodological challenges.\n\nThe survey further explores the application of machine learning and artificial intelligence in medical diagnostics, with a focus on deep learning architectures for medical imaging and biomarker analysis, as well as ensemble and transfer learning strategies for diagnostic enhancement. These sections illustrate the transformative potential of AI in improving diagnostic accuracy and efficiency, while also addressing the challenges associated with model interpretability and generalizability [2]. The paper also examines the integration of AI with traditional diagnostic techniques, emphasizing the need for hybrid approaches that combine the strengths of both domains. Additionally, the survey discusses computational methods for biomedical data interpretation, including temporal modeling of lab test records and feature selection and model optimization in AI-based diagnostics. These topics underscore the growing importance of data-driven approaches in modern diagnostic practices and the need for robust methodologies to ensure reliable outcomes.\n\nThis survey paper makes several key contributions to the field of diagnostic test accuracy studies [5]. It provides a comprehensive overview of the methodological and computational approaches currently used in DTA research, offering insights into their applications, limitations, and potential for future development. By integrating statistical, computational, and machine learning methodologies, the paper highlights the multidisciplinary nature of diagnostic accuracy evaluation and emphasizes the importance of rigorous methodological frameworks [1]. The survey also identifies gaps in current research and suggests areas for future investigation, such as the development of more robust sensitivity analysis techniques and the refinement of AI models for clinical use. These contributions aim to support the advancement of diagnostic test accuracy studies and promote the use of evidence-based methods in clinical practice."
    },
    {
      "heading": "3.1.1 Bayesian and Frequentist Approaches to Sample Size Determination",
      "level": 3,
      "content": "Bayesian and frequentist approaches to sample size determination represent two distinct paradigms in statistical inference, each with unique principles and implications for study design. Frequentist methods typically rely on pre-specified significance levels (α) and desired power (1 - β) to calculate the required sample size, often based on hypothesis testing frameworks. These approaches emphasize long-run frequency properties and are grounded in the assumption of fixed, true parameters. In contrast, Bayesian methods incorporate prior distributions to quantify uncertainty and focus on the probability of achieving a desired outcome, such as a specific posterior probability threshold. This probabilistic framework allows for more flexible and adaptive designs, particularly when prior information is available or when sequential monitoring is of interest.\n\nThe choice between Bayesian and frequentist methods often hinges on the study's objectives, the availability of prior information, and the complexity of the statistical model. Frequentist sample size calculations are widely used in clinical trials and observational studies due to their simplicity and regulatory acceptance. However, they can be limited in scenarios where prior knowledge is substantial or when the study design involves multiple stages. Bayesian methods, while more computationally intensive, offer advantages in situations with small sample sizes or when incorporating external evidence is critical. They also provide a more intuitive interpretation of results through posterior distributions, which can be particularly valuable in decision-making contexts.\n\nDespite their differences, both approaches face challenges in practical implementation, including the specification of appropriate priors in Bayesian settings and the assumptions underlying frequentist power calculations. Recent advancements have sought to bridge these gaps by integrating Bayesian and frequentist principles, such as using Bayesian assurance to inform frequentist power calculations. These hybrid approaches aim to leverage the strengths of both paradigms, offering more robust and adaptable solutions for sample size determination in complex research scenarios."
    },
    {
      "heading": "3.1.2 Sensitivity Analysis for Publication Bias and Data Quality",
      "level": 3,
      "content": "Sensitivity analysis plays a critical role in evaluating the robustness of diagnostic test accuracy (DTA) meta-analyses, particularly in the context of publication bias and data quality [6]. Publication bias arises when studies with statistically significant or favorable results are more likely to be published, leading to distorted estimates of diagnostic performance. This bias can significantly affect the summary receiver operating characteristic (SROC) curve and the area under the SROC curve (SAUC), which are commonly used to summarize test accuracy across studies [5]. Sensitivity analysis methods, such as those based on selection functions and likelihood-based approaches, aim to quantify the potential impact of such biases by modeling different publication mechanisms [7]. These techniques help assess how sensitive the results are to assumptions about missing studies and provide insights into the reliability of the meta-analytic findings.\n\nData quality is another crucial aspect in DTA meta-analyses, as incomplete or biased data can lead to misleading conclusions. Partial verification bias, where the gold standard test is not applied to all participants, is a common issue that can result in biased estimates of sensitivity and specificity. Sensitivity analysis techniques are employed to evaluate the extent to which such biases might affect the overall accuracy estimates. Methods such as multiple imputation and continuity-corrected confidence intervals are often used to address missing data and improve the validity of comparisons between diagnostic tests. These approaches help researchers understand how variations in data quality might influence the results and guide the selection of more reliable studies for inclusion in the meta-analysis [8].\n\nThe integration of sensitivity analysis into DTA meta-analyses is essential for ensuring the validity and generalizability of the findings [6]. By exploring a range of plausible scenarios, such as different selection probabilities and publication mechanisms, researchers can assess the stability of their conclusions. Interactive tools and visualization techniques further enhance the interpretability of these analyses, allowing users to explore the impact of publication bias on key metrics like the SROC curve and SAUC. Ultimately, a thorough sensitivity analysis not only strengthens the credibility of DTA meta-analyses but also informs the design of future studies by highlighting areas where data collection and reporting practices can be improved [6]."
    },
    {
      "heading": "3.2.1 Nonparametric and Likelihood-Based Techniques for ROC Curve Analysis",
      "level": 3,
      "content": "Nonparametric techniques for ROC curve analysis provide a flexible approach to evaluating diagnostic accuracy without assuming a specific distribution for the test results [9]. These methods, such as the Mann-Whitney estimator, focus on estimating the area under the ROC curve (AUC) and comparing the performance of multiple tests. They are particularly useful when the underlying data distribution is unknown or complex, as they rely on rank-based statistics rather than parametric assumptions. Nonparametric methods also allow for the estimation of confidence intervals and hypothesis testing, making them valuable tools for assessing the statistical significance of differences in diagnostic accuracy. These techniques are often implemented using bootstrap procedures to approximate the sampling distribution of the estimated ROC curves [9].\n\nLikelihood-based techniques, on the other hand, offer a more structured approach by modeling the relationship between test results and disease status through parametric or semiparametric models. These methods utilize maximum likelihood estimation to derive estimates of sensitivity, specificity, and other diagnostic measures, often incorporating covariates to adjust for confounding factors. By explicitly modeling the data-generating process, likelihood-based approaches can provide more efficient and precise estimates, particularly when the assumptions of the model are met. They also enable the construction of confidence intervals and hypothesis tests through likelihood ratio or Wald statistics. Furthermore, these techniques can be extended to handle censored or correlated data, making them suitable for complex diagnostic scenarios.\n\nThe integration of nonparametric and likelihood-based techniques allows for a comprehensive evaluation of diagnostic test performance. Nonparametric methods provide robustness against distributional assumptions, while likelihood-based approaches offer greater efficiency and flexibility in modeling. This combination is especially beneficial in meta-analysis of diagnostic accuracy studies, where heterogeneity in study designs and populations is common [6]. Techniques such as the bivariate random-effects model and the hierarchical summary receiver operating characteristic (HSROC) model incorporate both approaches to account for between-study variability and provide pooled estimates of diagnostic accuracy. These methods are essential for synthesizing evidence from multiple studies and drawing reliable conclusions about the performance of diagnostic tests in real-world settings [5]."
    },
    {
      "heading": "3.2.2 Transformation Models for Covariate-Adjusted Diagnostic Performance",
      "level": 3,
      "content": "Transformation models provide a flexible framework for adjusting diagnostic performance metrics by incorporating covariates that influence the distribution of test results. These models allow for the estimation of covariate-specific ROC curves and summary indices, enabling a more nuanced understanding of diagnostic accuracy across different patient subgroups [9]. By specifying a parametric model for the transformation of test results, these approaches can account for non-linear relationships and interactions between covariates and diagnostic markers. This is particularly useful in settings where the discriminatory ability of a test varies with patient characteristics, such as age, gender, or comorbidities, thus improving the generalizability and clinical relevance of diagnostic evaluations.\n\nThe application of transformation models in diagnostic performance analysis involves jointly estimating the transformation function and regression parameters, which allows for the assessment of how covariates affect both the distribution of test results and the overall discriminatory power of the diagnostic test. These models remain distribution-free in the sense that they do not impose strict assumptions on the underlying data distribution, making them robust to various data structures. By using maximum likelihood estimation, researchers can derive confidence bands for the ROC curve and confidence intervals for summary indices, ensuring that inferences are valid and invariant to reparametrizations [4]. This methodological flexibility is essential for accurately evaluating the impact of covariates on diagnostic performance in real-world medical settings.\n\nFurthermore, transformation models offer a systematic approach to comparing the efficacy of multiple diagnostic tests while adjusting for potential confounding variables. This is particularly important in studies where the verification of disease status is incomplete or biased, as the models can account for such complexities through appropriate adjustments. By incorporating covariates into the analysis, these models provide more accurate and reliable estimates of diagnostic accuracy, which is critical for evidence-based medical decision-making. The ability to model the relationship between test results and covariates also facilitates the development of personalized diagnostic strategies, enhancing the precision and effectiveness of clinical diagnostics."
    },
    {
      "heading": "3.3.1 Empirical Evaluation of Diagnostic Reliability Under Variability",
      "level": 3,
      "content": "The empirical evaluation of diagnostic reliability under variability is a critical component in assessing the robustness of binary diagnostic tests (BDTs) across different conditions and populations. Variability in disease prevalence, test performance, and the presence of partial disease verification introduce significant challenges in estimating diagnostic accuracy [1]. Under the assumption of missing at random (MAR), studies have explored methods to compare sensitivities and specificities of BDTs, often employing maximum likelihood techniques to account for incomplete verification. However, the reliability of these estimates hinges on the validity of the MAR assumption, which may not always hold in practice. Empirical validation through simulation studies and real-world data is essential to evaluate how well these methods perform under varying degrees of data incompleteness and disease distribution.\n\nEmpirical assessments also highlight the limitations of global performance metrics such as accuracy and the area under the ROC curve (AUC), which may obscure important group-specific variations in diagnostic performance [10]. For instance, while AUC provides a comprehensive measure of overall test accuracy, it may fail to capture the nuanced differences in performance across subgroups, such as high-risk populations with distinct prevalence rates. This can lead to misleading conclusions about the effectiveness of a diagnostic test in specific clinical contexts. Therefore, empirical studies often incorporate subgroup analyses and evaluate metrics like balanced accuracy, sensitivity, and specificity to provide a more granular understanding of diagnostic reliability under different scenarios.\n\nFinally, the reliability of diagnostic tests under variability is further influenced by the presence of publication bias (PB) and the complexity of meta-analytical methods used to synthesize evidence across studies [5]. Techniques such as bivariate meta-analysis and the construction of summary receiver operating characteristic (SROC) curves are commonly employed to account for correlations between sensitivity and specificity [11]. However, the accuracy of these methods depends on the quality and representativeness of the included studies. Empirical evaluations that systematically assess the impact of PB and other biases on diagnostic reliability are crucial for ensuring the validity of meta-analytic conclusions and guiding the development of more robust diagnostic evaluation frameworks."
    },
    {
      "heading": "3.3.2 Simulation-Driven Analysis of Diagnostic Accuracy and Uncertainty",
      "level": 3,
      "content": "Simulation-driven analysis of diagnostic accuracy and uncertainty is a critical approach for evaluating the performance of binary diagnostic tests (BDTs) under varying conditions and data structures. This method leverages computational simulations to assess how diagnostic accuracy measures, such as sensitivity, specificity, and predictive values, behave across different scenarios, including those with partial disease verification or missing data. By generating synthetic datasets that mimic real-world clinical settings, researchers can systematically investigate the impact of factors like disease prevalence, test characteristics, and verification bias on diagnostic outcomes. This approach enables a deeper understanding of the limitations and robustness of diagnostic tests, especially when the gold standard is not fully available or when verification is not random.\n\nThe simulation framework also plays a vital role in quantifying and propagating uncertainty in diagnostic accuracy estimates. Uncertainty arises from multiple sources, including sampling variability, model misspecification, and incomplete verification of disease status. Through Monte Carlo simulations, researchers can estimate the distribution of accuracy metrics and construct confidence intervals that reflect the variability in the data. This is particularly important when comparing two or more diagnostic tests, as it allows for the assessment of statistical significance and the identification of tests that maintain consistent performance across different subgroups. Furthermore, simulation-driven methods can be used to evaluate the impact of different statistical models, such as bivariate or hierarchical models, on the estimation of summary operating points (SOPs) and area under the curve (AUC) metrics.\n\nIn addition to evaluating accuracy, simulation-driven analysis is instrumental in exploring the effects of covariates and model complexity on diagnostic performance. By incorporating covariates into the simulation process, researchers can assess how factors such as age, gender, or comorbidities influence the accuracy of a diagnostic test. This is essential for developing personalized diagnostic strategies and understanding the heterogeneity in test performance across different populations. Moreover, the use of simulation allows for the development of robust diagnostic models that can adapt to changing conditions and data structures. Overall, simulation-driven analysis provides a powerful tool for advancing the evaluation and interpretation of diagnostic accuracy, ensuring that findings are reliable, interpretable, and applicable in real-world clinical settings."
    },
    {
      "heading": "4.1.1 Deep Learning Architectures for Medical Imaging and Biomarker Analysis",
      "level": 3,
      "content": "Deep learning architectures have revolutionized medical imaging and biomarker analysis by enabling automated feature extraction, pattern recognition, and high-accuracy diagnostic predictions. Convolutional neural networks (CNNs) have become the cornerstone of image-based analysis, excelling in tasks such as tumor detection, segmentation, and classification. These models leverage hierarchical feature learning to capture intricate spatial relationships in medical images, including histopathological slides, radiographic scans, and fluorescence microscopy data. Recent advancements have integrated CNNs with attention mechanisms and transformer-based architectures to enhance interpretability and capture long-range dependencies, improving performance in complex diagnostic scenarios.\n\nTransformers and hybrid models have further expanded the capabilities of deep learning in medical imaging by addressing limitations in local receptive fields and scalability. These architectures are particularly effective in multi-modal settings, where data from different sources—such as imaging, genomics, and clinical records—are combined for comprehensive analysis. For instance, multi-modal models integrate features from histopathological images and genetic data to predict molecular biomarkers, enabling more accurate disease stratification. Additionally, self-supervised and contrastive learning techniques have been employed to train models on limited annotated datasets, reducing dependency on large-scale labeled data while maintaining robust performance.\n\nThe application of deep learning in biomarker analysis extends beyond image processing to include the identification of molecular signatures from high-throughput data. Techniques such as autoencoders and graph neural networks are used to extract meaningful representations from genomic and proteomic datasets, facilitating the discovery of novel biomarkers. These models are often optimized using automated machine learning (AutoML) pipelines, which streamline hyperparameter tuning and model selection [12]. By leveraging these advanced architectures, researchers can uncover subtle patterns in complex biomedical data, ultimately enhancing early diagnosis, personalized treatment, and disease monitoring in clinical practice."
    },
    {
      "heading": "4.1.2 Ensemble and Transfer Learning Strategies for Diagnostic Enhancement",
      "level": 3,
      "content": "Ensemble and transfer learning strategies have emerged as critical techniques for enhancing diagnostic accuracy in medical applications, particularly when dealing with limited or heterogeneous data. Ensemble methods combine multiple models to improve robustness and generalization, mitigating the risks of overfitting and increasing predictive reliability. Techniques such as bagging, boosting, and stacking are widely applied to aggregate predictions from diverse models, leveraging their individual strengths while reducing variance. In the context of diagnostic systems, ensemble learning can integrate outputs from different feature extractors or classifiers, leading to more consistent and accurate results. Transfer learning, on the other hand, enables the adaptation of pre-trained models to new diagnostic tasks by leveraging knowledge from related domains, which is especially beneficial when labeled data is scarce or expensive to obtain.\n\nThe integration of ensemble and transfer learning strategies has shown significant promise in improving diagnostic performance across various medical imaging and spectroscopy-based applications. For instance, pre-trained models from large-scale datasets can be fine-tuned on specialized medical data, allowing for the extraction of more discriminative features. When combined with ensemble techniques, this approach can further enhance model stability and reduce the impact of noisy or imbalanced data. In the case of spectroscopy-based diagnostics, where data variability is high, the use of ensemble learning helps in capturing a broader range of spectral patterns, while transfer learning ensures that the model remains effective even when deployed in new environments or with different instrumentation. These strategies collectively contribute to more reliable and adaptable diagnostic systems.\n\nMoreover, the synergy between ensemble and transfer learning can address challenges such as domain shift and data scarcity, which are common in real-world diagnostic scenarios. By combining the strengths of multiple models and leveraging prior knowledge, these techniques enable the development of more generalizable and efficient diagnostic systems. In applications where rapid deployment is essential, such as point-of-care testing, the use of transfer learning can significantly reduce training time and computational requirements. Meanwhile, ensemble methods ensure that the system remains robust to variations in input data and environmental conditions. Together, these strategies provide a powerful framework for enhancing diagnostic accuracy, reliability, and adaptability in diverse medical settings."
    },
    {
      "heading": "4.2.1 Application of Neural Networks in Rapid Test Image Analysis",
      "level": 3,
      "content": "Neural networks have emerged as powerful tools for analyzing rapid test images, enabling automated and accurate interpretation of diagnostic results. These models, particularly convolutional neural networks (CNNs), are adept at extracting relevant features from images, such as color intensity, line visibility, and pattern recognition, which are critical for interpreting rapid tests. By training on large datasets of labeled test images, neural networks can learn to distinguish between positive and negative results with high precision, reducing the need for manual interpretation and minimizing human error. This capability is especially valuable in point-of-care settings where rapid and reliable diagnosis is essential.\n\nThe application of neural networks in rapid test image analysis involves several key steps, including image preprocessing, feature extraction, and classification. Preprocessing techniques such as normalization, contrast enhancement, and noise reduction are often employed to improve image quality and ensure consistent input for the neural network. Feature extraction is typically handled through convolutional layers that automatically identify relevant patterns, while fully connected layers perform the final classification. Additionally, techniques like transfer learning and data augmentation are frequently used to enhance model generalization and performance, particularly when dealing with limited or imbalanced datasets.\n\nRecent advancements have further improved the accuracy and efficiency of neural networks in this domain. For instance, architectures such as YOLOv8 and custom CNNs have been developed to handle real-time image analysis, making them suitable for mobile and portable diagnostic devices. Moreover, the integration of explainability techniques, such as attention maps and saliency analysis, has enhanced the interpretability of neural network predictions, fostering trust among clinicians. These developments underscore the transformative potential of neural networks in revolutionizing rapid test image analysis and supporting more accessible and accurate diagnostic solutions."
    },
    {
      "heading": "4.2.2 Integration of AI with Traditional Diagnostic Techniques",
      "level": 3,
      "content": "The integration of artificial intelligence (AI) with traditional diagnostic techniques has emerged as a transformative approach in modern medicine, enhancing both accuracy and efficiency in disease detection [2]. Traditional diagnostic methods, such as histopathological analysis, imaging, and biochemical assays, have long been the cornerstone of clinical decision-making. However, these methods often face limitations in terms of speed, reproducibility, and the ability to handle complex, high-dimensional data. AI, particularly through machine learning and deep learning models, offers a complementary approach by automating feature extraction, pattern recognition, and decision-making. This synergy allows for the refinement of conventional techniques, enabling earlier and more precise diagnoses, especially in complex conditions such as cancer, neurological disorders, and infectious diseases.\n\nAI-driven integration with traditional diagnostics has been particularly impactful in areas such as pathology and radiology, where image-based analysis is critical. Techniques like convolutional neural networks (CNNs) have been employed to analyze histopathological slides and radiographic images, identifying subtle patterns that may be missed by human observers. Moreover, AI models can process large volumes of data rapidly, reducing the time required for diagnosis and enabling real-time decision support. This has been especially beneficial in resource-limited settings, where access to specialized expertise is constrained. By augmenting traditional methods with AI, diagnostic workflows become more robust, scalable, and adaptable to diverse clinical environments, ultimately improving patient outcomes.\n\nThe fusion of AI with conventional diagnostic tools also facilitates the development of hybrid systems that combine the strengths of both approaches. For instance, AI can be used to preprocess and annotate data, guiding human experts in their interpretations and reducing the likelihood of errors. Additionally, AI models can be trained on diverse datasets to generalize across different populations and clinical scenarios, enhancing their applicability. As the field continues to evolve, the integration of AI with traditional diagnostic techniques is expected to drive further innovation, leading to more personalized, efficient, and accurate diagnostic solutions that address the growing demands of modern healthcare [2]."
    },
    {
      "heading": "4.3.1 Temporal Modeling of Lab Test Records for Predictive Diagnostics",
      "level": 3,
      "content": "Temporal modeling of lab test records plays a crucial role in predictive diagnostics by capturing the dynamic evolution of a patient's health status over time [13]. Traditional diagnostic approaches often rely on static biomarker values, which may not fully reflect the complex and evolving nature of diseases [14]. By treating lab test histories as time-series data, temporal modeling techniques can uncover hidden patterns and sequential dependencies that are critical for early detection and accurate prognosis [13]. This approach is particularly valuable in conditions where disease progression is nonlinear and influenced by multiple interacting factors, such as chronic illnesses or complex infections. The integration of temporal modeling into diagnostic frameworks enables more personalized and context-aware predictions, enhancing the clinical utility of laboratory data.\n\nRecent advances in machine learning have enabled the application of deep learning architectures, such as Long Short-Term Memory (LSTM) networks and Transformers, to model the temporal dynamics of lab test records [13]. These models can effectively process sequential data, even when the data is sparse or incomplete, by learning temporal dependencies and capturing the progression of biomarkers over time. Additionally, word embedding techniques have been adapted to represent lab test results as structured sequences, allowing for the extraction of meaningful diagnostic signals. Such methods not only improve the accuracy of predictive models but also provide insights into the underlying biological mechanisms driving disease progression. By leveraging temporal information, these models can support both early detection and differential diagnosis, offering a more comprehensive view of a patient's health trajectory.\n\nThe application of temporal modeling in predictive diagnostics extends beyond individual disease states, enabling the identification of broader trends and risk factors across populations. This capability is especially relevant in resource-limited settings where access to continuous monitoring is constrained. By utilizing historical lab data, these models can detect subtle changes in biomarker profiles that may indicate the onset of disease or deterioration in health status. Furthermore, the ability to handle incomplete or irregularly sampled data makes temporal modeling robust to real-world clinical scenarios. As the field continues to evolve, the integration of temporal modeling into diagnostic workflows promises to enhance the precision, efficiency, and scalability of predictive healthcare solutions."
    },
    {
      "heading": "4.3.2 Feature Selection and Model Optimization in AI-Based Diagnostics",
      "level": 3,
      "content": "Feature selection and model optimization play a critical role in enhancing the performance and interpretability of AI-based diagnostic systems. In this section, we discuss the methodologies employed to identify the most relevant features from high-dimensional datasets, which are essential for improving model accuracy and reducing computational complexity. Various feature selection techniques, including filter, wrapper, and embedded methods, are evaluated based on their ability to retain discriminative information while eliminating redundant or irrelevant features [15]. The choice of feature selection method is influenced by the nature of the data, the complexity of the diagnostic task, and the need for model generalization. For instance, correlation-based feature selection (CFS) and recursive feature elimination (RFE) are commonly used to identify features that contribute most significantly to the diagnostic outcome. These strategies are crucial in ensuring that the models are both efficient and effective in clinical settings.\n\nModel optimization involves the fine-tuning of hyperparameters to enhance the predictive power of AI models while preventing overfitting. Techniques such as grid search, random search, and Bayesian optimization are employed to explore the hyperparameter space and identify the optimal configuration. In the context of diagnostic applications, model optimization also includes the evaluation of different algorithms, such as support vector machines (SVM), random forests, and deep learning architectures, to determine the most suitable model for the given task. The integration of automated machine learning (AutoML) tools further streamlines this process by enabling the automatic selection of features and hyperparameters, reducing the need for manual intervention [12]. This automation not only improves the reproducibility of diagnostic models but also accelerates the development and deployment of AI-driven diagnostic systems.\n\nThe interplay between feature selection and model optimization is essential for achieving robust and reliable diagnostic outcomes. A well-optimized model that leverages a carefully selected set of features can significantly improve the accuracy and efficiency of disease detection. This synergy is particularly important in resource-constrained environments, where computational resources are limited and diagnostic accuracy must be maximized. By systematically evaluating different feature selection and model optimization strategies, this section provides insights into best practices for developing AI-based diagnostic systems that are both effective and scalable. The methodologies discussed here serve as a foundation for future research and practical implementation in the field of medical diagnostics."
    },
    {
      "heading": "5.1.1 Comparative Analysis of AI and Conventional Diagnostic Systems",
      "level": 3,
      "content": "The comparative analysis of AI and conventional diagnostic systems reveals significant differences in performance, adaptability, and clinical utility. AI models, particularly those based on deep learning architectures, have demonstrated high diagnostic accuracy in identifying abnormalities in neuroimaging tasks, often matching or surpassing human experts in specific scenarios [8]. However, conventional systems, which rely on rule-based algorithms and explicit feature engineering, remain robust in settings where interpretability and simplicity are prioritized. While AI systems offer the potential for automation and scalability, they often require extensive data and computational resources, which can limit their deployment in resource-constrained environments. Conventional methods, on the other hand, are more established, with well-documented validation processes, making them a reliable choice in many clinical settings.\n\nThe impact of AI on downstream clinical outcomes is a critical factor in evaluating its integration into diagnostic workflows. Studies have shown that AI can enhance diagnostic speed and reduce workload, particularly in high-volume neuroimaging tasks, which are prevalent in modern healthcare systems [8]. However, the translation of AI-driven diagnostics into improved patient outcomes remains inconsistent, with limited evidence of direct clinical benefit in many cases. Conventional diagnostic systems, while slower, often provide clearer decision pathways that align with established clinical guidelines. This suggests that AI may serve as a complementary tool rather than a replacement, particularly in complex diagnostic scenarios where human judgment and contextual understanding are essential.\n\nDespite the advancements in AI, conventional diagnostic systems continue to hold an advantage in terms of interpretability and integration with existing clinical workflows. The use of machine learning techniques, such as multivariate logistic regression, remains prevalent in certain applications due to their transparency and ease of implementation. Additionally, traditional statistical methods have shown comparable effectiveness in neuro-oncology monitoring, indicating that AI is not always superior in every diagnostic context [8]. As the field evolves, a balanced approach that leverages the strengths of both AI and conventional systems will be crucial for optimizing diagnostic accuracy and clinical outcomes."
    },
    {
      "heading": "5.1.2 Meta-Analysis of Diagnostic Accuracy Across Medical Domains",
      "level": 3,
      "content": "The section on meta-analysis of diagnostic accuracy across medical domains presents a comprehensive synthesis of studies evaluating the performance of machine learning (ML)-based biomarkers in diagnosing treatment response in glioblastoma [16]. This analysis integrates findings from a range of diagnostic accuracy studies, employing standardized statistical techniques to assess sensitivity, specificity, and other relevant metrics [3]. By aggregating data from multiple sources, the meta-analysis aims to provide a robust estimate of the overall diagnostic performance, while also identifying variations across different medical domains and study designs [6]. The methodology emphasizes the importance of systematic review protocols to ensure the reliability and validity of the aggregated results.\n\nThe diagnostic accuracy of ML-based biomarkers is evaluated through a structured approach that incorporates both quantitative and qualitative assessments. This includes the use of statistical models such as random-effects or fixed-effects meta-analysis to account for heterogeneity among studies. The analysis also considers the impact of study quality, sample size, and methodological rigor on the overall diagnostic performance. By applying tools like the QUADAS-2 framework, the review ensures that the included studies meet predefined quality criteria, thereby enhancing the credibility of the meta-analytic findings. These insights are crucial for understanding the clinical utility and generalizability of ML-based diagnostic tools in diverse medical settings.\n\nThe findings from the meta-analysis reveal significant variability in diagnostic accuracy across different medical domains, highlighting the need for domain-specific validation and adaptation of ML models [6]. While some studies demonstrate high sensitivity and specificity, others show lower performance, often due to differences in data characteristics, model architecture, or clinical context. These results underscore the importance of continued research to refine and optimize ML-based diagnostic tools, ensuring they meet the diverse needs of clinical practice. The meta-analysis serves as a foundational reference for future studies, guiding the development of more accurate and reliable diagnostic solutions in neuro-oncology and beyond."
    },
    {
      "heading": "5.2.1 Performance Assessment of LLMs in Clinical Question Answering",
      "level": 3,
      "content": "The performance assessment of large language models (LLMs) in clinical question answering has become a critical area of investigation, given their increasing integration into medical decision support systems [17]. Recent studies have evaluated LLMs using standardized datasets designed to reflect real-world clinical scenarios, such as the 105,222 short multiple-choice questions derived from medical articles [17]. These assessments typically measure accuracy, relevance, and the ability to provide contextually appropriate responses. However, the results reveal significant variability, with some models excelling in specific domains while underperforming in others. The challenge lies in ensuring that LLMs can reliably interpret and respond to complex clinical queries, especially those involving nuanced medical knowledge or patient-specific data.\n\nWhile LLMs demonstrate impressive capabilities in processing textual information and generating coherent responses, their performance in clinical settings remains inconsistent. Factors such as the quality of training data, model architecture, and the nature of the questions significantly influence outcomes. For instance, models trained on extensive medical literature may perform well on factual queries but struggle with tasks requiring clinical reasoning or interpretation of non-textual data, such as medical codes. Additionally, the absence of rigorous validation protocols in many studies limits the generalizability of findings, highlighting the need for standardized evaluation frameworks that reflect real-world clinical workflows.\n\nDespite these challenges, ongoing research continues to refine LLMs for clinical applications, with a focus on improving accuracy, transparency, and interpretability. The development of specialized benchmarks, such as those targeting mathematical perception or diagnostic accuracy, underscores the importance of domain-specific evaluation. As LLMs evolve, their performance in clinical question answering will likely improve, but sustained efforts are required to address limitations and ensure their reliability in critical healthcare contexts [17]."
    },
    {
      "heading": "5.2.2 Case Studies on AI Model Behavior in Complex Medical Scenarios",
      "level": 3,
      "content": "Case studies on AI model behavior in complex medical scenarios reveal significant variations in performance and reliability across different clinical applications. Several studies have evaluated AI models in diagnostic settings, with some demonstrating high accuracy comparable to or exceeding that of human experts. These models often employ advanced architectures such as convolutional neural networks (CNNs) and graph neural networks (GNNs), which are particularly effective in analyzing medical imaging and complex data structures. However, the integration of AI into clinical workflows remains challenging, as many models lack robustness in real-world conditions and fail to generalize across diverse patient populations. The evaluation of these models in controlled environments has provided valuable insights, but their performance in unstructured clinical settings remains an open question.\n\nIn the domain of neuro-oncology, AI models have been developed to monitor treatment responses and identify biomarkers, yet their clinical utility is still under investigation [16]. While some studies have shown promise in leveraging machine learning for predictive modeling, others have found that traditional statistical methods often perform equally well or better, particularly when computational resources are limited. The development of AI-driven diagnostic tools has also been hindered by the complexity of medical knowledge, which is inherently semantic and requires the integration of vast amounts of evidence-based information. This has led to the creation of specialized datasets and knowledge graphs aimed at improving the interpretability and reliability of AI models in clinical contexts.\n\nThe application of AI in Alzheimer’s disease diagnosis has further highlighted the importance of structured data representation, such as graph-based models that capture the complex connectivity of brain regions [18]. These models, like ADiag, demonstrate the potential of GNNs in capturing the nuanced relationships within medical data. However, the reliance on supervised learning and the need for large annotated datasets remain critical limitations. As AI continues to evolve, case studies on its behavior in complex medical scenarios will be essential in guiding the development of more accurate, interpretable, and clinically viable models."
    },
    {
      "heading": "5.3.1 Systematic Review Frameworks for Diagnostic Accuracy Studies",
      "level": 3,
      "content": "Systematic review frameworks for diagnostic accuracy studies are essential for synthesizing evidence from multiple studies to evaluate the performance of diagnostic tests [3]. These frameworks provide structured methodologies to ensure rigorous and transparent evaluation of diagnostic accuracy, which is critical in clinical decision-making. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy (PRISMA-DTA) statement outlines key elements that should be reported in such reviews, including study selection, data extraction, and risk of bias assessment [6]. This framework ensures consistency and enhances the reliability of findings, enabling clinicians and researchers to make informed decisions based on high-quality evidence.\n\nA key component of systematic review frameworks is the use of standardized tools to assess the quality of included studies. The QUADAS-2 tool, for instance, is widely used to evaluate the methodological quality of diagnostic accuracy studies by assessing domains such as patient selection, index test, reference standard, and flow and timing. These tools help identify potential biases and limitations, thereby improving the validity of the review's conclusions. Additionally, systematic reviews often employ statistical methods such as meta-analysis to combine results from multiple studies, providing a more comprehensive understanding of diagnostic test performance across different populations and settings [6].\n\nThe application of systematic review frameworks in diagnostic accuracy studies has evolved significantly, driven by the need for robust evidence in rapidly advancing fields such as neuro-oncology and artificial intelligence. As diagnostic technologies and biomarkers become more complex, the demand for rigorous evaluation frameworks increases [14]. These frameworks not only support the integration of new diagnostic tools into clinical practice but also highlight gaps in current research, guiding future studies. By adhering to established methodologies, systematic reviews contribute to the development of evidence-based diagnostic strategies, ultimately improving patient outcomes and healthcare delivery."
    },
    {
      "heading": "5.3.2 Meta-Analysis Techniques for Diagnostic Test Evaluation",
      "level": 3,
      "content": "Meta-analysis techniques for diagnostic test evaluation are essential tools for synthesizing evidence from multiple studies to assess the accuracy of diagnostic tests [6]. These methods allow researchers to aggregate data from various sources, providing a more robust estimate of sensitivity, specificity, and other performance metrics. Commonly used approaches include bivariate and hierarchical models, which account for the correlation between sensitivity and specificity and the variability across studies. These techniques are particularly valuable in fields such as neuro-oncology, where diagnostic accuracy can significantly impact patient outcomes. The application of meta-analysis in this context is critical for evaluating the performance of imaging modalities and artificial intelligence models in detecting conditions like tumor progression.\n\nA key challenge in conducting meta-analyses for diagnostic tests is ensuring the homogeneity of included studies [6]. Heterogeneity in study design, patient populations, and diagnostic criteria can affect the reliability of pooled estimates. In some cases, meta-analysis is only feasible for subgroups with sufficient consistency in imaging modalities, target conditions, and AI model types. Additionally, the absence of formal assessments for publication bias may limit the generalizability of findings. Despite these limitations, meta-analysis remains a powerful method for evaluating diagnostic test performance, especially when combined with rigorous systematic review protocols to ensure methodological transparency and reproducibility [6].\n\nThe evolving nature of diagnostic methodologies, particularly in radiomics and AI-driven diagnostics, necessitates continuous updates to meta-analytic approaches. As new studies emerge, the need for updated systematic reviews and meta-analyses becomes more pressing to reflect the current state of evidence. Techniques such as subgroup analysis and sensitivity analysis are often employed to explore sources of heterogeneity and assess the stability of results. These methods not only enhance the validity of diagnostic test evaluations but also support evidence-based decision-making in clinical practice, ultimately contributing to improved patient care and outcomes."
    },
    {
      "heading": "6 Future Directions",
      "level": 1,
      "content": "Despite significant advancements in diagnostic test accuracy (DTA) research, several limitations and gaps remain that hinder the robust evaluation and application of diagnostic methods in clinical practice. One major limitation is the persistent challenge of addressing biases such as partial verification bias and publication bias, which can distort the estimation of diagnostic performance metrics. While existing methodologies provide tools for sensitivity analysis and bias correction, their application remains inconsistent across studies, particularly in heterogeneous clinical settings. Additionally, the integration of machine learning and artificial intelligence into DTA studies is still in its early stages, with limited guidance on how to validate and interpret these models in real-world diagnostic contexts. The lack of standardized frameworks for evaluating the generalizability and clinical utility of AI-based diagnostic tools further complicates their adoption. Moreover, there is a need for more rigorous computational and simulation-based approaches to assess the reliability of diagnostic accuracy estimates under varying conditions, especially when data is incomplete or subject to verification bias.\n\nTo address these challenges, future research should focus on developing more robust and adaptable statistical methods for DTA studies. This includes the refinement of sensitivity analysis techniques to better account for biases in real-world data, as well as the integration of advanced computational tools for simulating diagnostic accuracy under different scenarios. The development of hybrid models that combine traditional statistical approaches with machine learning techniques could also enhance the flexibility and reliability of diagnostic evaluations. Furthermore, there is a need to establish standardized protocols for the validation and implementation of AI-driven diagnostic systems, ensuring their transparency, interpretability, and clinical relevance. Research should also explore the application of transformation models and covariate-adjusted diagnostic performance metrics to improve the accuracy of test evaluations across diverse patient populations. By addressing these methodological gaps, future work can contribute to the development of more reliable and generalizable diagnostic tools that support evidence-based clinical decision-making.\n\nThe potential impact of these future research directions is substantial, as they can significantly improve the quality and reliability of diagnostic test evaluations. Enhanced statistical and computational methodologies will enable more accurate estimation of diagnostic performance, leading to better-informed clinical decisions and improved patient outcomes. The integration of AI and machine learning into DTA studies has the potential to revolutionize diagnostic practices by enabling faster, more precise, and personalized diagnostic assessments. Additionally, the development of standardized validation frameworks for AI-based tools will facilitate their safe and effective implementation in clinical settings. By addressing current limitations and exploring new methodological approaches, future research in DTA can contribute to the advancement of medical diagnostics, ultimately enhancing the accuracy, efficiency, and accessibility of healthcare services. These efforts will be critical in ensuring that diagnostic test evaluations remain robust, reliable, and applicable across diverse clinical and research contexts."
    },
    {
      "heading": "7 Conclusion",
      "level": 1,
      "content": "The conclusion of this survey paper highlights the critical advancements and methodological developments in the field of diagnostic test accuracy (DTA) over the past few decades. The paper provides a comprehensive overview of statistical methods, computational techniques, and machine learning applications that have been employed to evaluate the performance of diagnostic tests. Key findings include the increasing use of Bayesian and frequentist approaches for sample size determination, the importance of sensitivity analysis to address publication bias and data quality, and the development of advanced statistical models such as nonparametric and likelihood-based techniques for ROC curve analysis. Additionally, the paper discusses the application of transformation models for covariate-adjusted diagnostic performance and the role of simulation-driven analysis in assessing diagnostic reliability under variability. The integration of machine learning and artificial intelligence into medical diagnostics has also been explored, emphasizing their potential to enhance diagnostic accuracy and efficiency. These findings collectively underscore the evolving landscape of DTA studies and the need for robust methodologies to ensure the validity and generalizability of diagnostic accuracy estimates.\n\nThe significance of this survey lies in its contribution to the ongoing discourse on improving the quality and reliability of diagnostic test accuracy studies. By synthesizing existing literature and examining current methodologies, the paper provides valuable insights into the strengths and limitations of various approaches, as well as their applicability in different clinical contexts. The emphasis on statistical rigor, computational techniques, and the integration of machine learning highlights the multidisciplinary nature of DTA research and the importance of adopting evidence-based methods in clinical practice. Furthermore, the survey identifies gaps in current research and suggests areas for future investigation, such as the development of more robust sensitivity analysis techniques and the refinement of AI models for clinical use. These contributions aim to support the advancement of DTA studies and promote the use of reliable and valid diagnostic evaluation frameworks.\n\nIn conclusion, this survey underscores the critical need for continued research and innovation in the field of diagnostic test accuracy. As healthcare systems increasingly rely on accurate and reliable diagnostic tools, the development and application of robust methodologies remain essential. Future efforts should focus on addressing methodological challenges, improving the generalizability of diagnostic accuracy estimates, and leveraging emerging technologies to enhance diagnostic efficiency and precision. The integration of statistical, computational, and machine learning approaches will be crucial in advancing the field and ensuring that diagnostic tests meet the evolving demands of modern healthcare. By fostering interdisciplinary collaboration and promoting evidence-based practices, the field of DTA can continue to make meaningful contributions to improving patient outcomes and clinical decision-making."
    }
  ],
  "references": [
    "[1] Correcting for partial verification bias in diagnostic accuracy studies  A tutorial using R",
    "[2] AI-Driven Smartphone Solution for Digitizing Rapid Diagnostic Test Kits and Enhancing Accessibility",
    "[3] Bayesian sample size determination for diagnostic accuracy studies",
    "[4] Transformation models for ROC analysis",
    "[5] A likelihood based sensitivity analysis for publication bias on summary ROC in meta-analysis of diag",
    "[6] MVPBT  R package for publication bias tests in meta-analysis of diagnostic accuracy studies",
    "[7] Nonparametric worst-case bounds for publication bias on the summary receiver operating characteristi",
    "[8] Artificial intelligence for abnormality detection in high volume neuroimaging  a systematic review a",
    "[9] A new test for assessing the covariate effect in ROC curves",
    "[10] Deep ROC Analysis and AUC as Balanced Average Accuracy to Improve Model Selection, Understanding and",
    "[11] DTAmetasa  an R shiny application for meta-analysis of diagnostic test accuracy and sensitivity anal",
    "[12] Diagnosis of sickle cell anemia using AutoML on UV-Vis absorbance spectroscopy data",
    "[13] Utilizing Sequential Information of General Lab-test Results and Diagnoses History for Differential",
    "[14] Transformation Discriminant Analysis for Constructing Optimal Biomarker Combinations",
    "[15] Machine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet o",
    "[16] Machine Learning and Glioblastoma  Treatment Response Monitoring Biomarkers in 2021",
    "[17] Performance of large language models in numerical vs. semantic medical knowledge  Benchmarking on ev",
    "[18] ADiag  Graph Neural Network Based Diagnosis of Alzheimer's Disease"
  ]
}